Dear Colleagues,

Join us for an exciting event, when The Inflammation Network hosts is 3rd Lightrail Seminar.

The LightRail Seminar series aims to bridge basic and clinical inflammation & infection research at AU and AUH. You can look forward to presentations and discussions with researchers from Health, Aarhus University

Host: Torben Steiniche

Tentative programme:

Torben Steiniche: Hallmarks of cancer
Introducing inflammation as a hallmark underscores the dual role of the immune system in cancer: it can both fight against and promote tumor growth.

Anne Helene Køstner: Fueling the flames of colon cancer – Tumor-associated Inflammation – a double-edged sword.
The association between systemic inflammation, as shown by markers like CRP, and cancer highlights the significance of the inflammatory response in the progression and outcome of the disease. It suggests that targeting inflammation could be a valuable strategy in cancer therapy.

Henrik Schmidt: Using the immune system to target cancer.
Using the immune system to target cancer has transformed the landscape of cancer treatment, offering hope for many patients with previously untreatable cancers.  

Christian Lodberg Hvas: The intestinal microbiome and cancer therapies – a case for fecal microbiota transplantation?

Louise Bønnelykke-Behrndtz: Surgery-induced inflammation, as a triggering origin of metastatic development
Inflammation is a hallmark of cancer, but also a hallmark of wound healing - thus understanding how to modulate surgery-induced inflammation may represent effective and early targets of treatment.